Disease_category,Disease,Protein,Protein_definition,method,nsnp,OR [95% CI],Pvalue,QTL_type
Chapter IX Diseases of the circulatory system,I9_VASCINT,WFDC2,WAP four-disulfide core domain protein 2,Inverse variance weighted,2,0.53 [0.24-1.17],0.117033872277696,cis
Chapter IX Diseases of the circulatory system,I9_VASCINT,GDF15,Growth/differentiation factor 15,Inverse variance weighted,12,0.76 [0.42-1.37],0.356102664623259,cis
Chapter IX Diseases of the circulatory system,I9_VASCINT,TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,Inverse variance weighted,25,0.98 [0.82-1.16],0.788904558900244,cis
Chapter IX Diseases of the circulatory system,I9_VASCINT,ANGPT2,Angiopoietin-2,Inverse variance weighted,4,1.01 [0.62-1.65],0.966960683703099,cis
Chapter IX Diseases of the circulatory system,I9_VASCINT,WFDC2,WAP four-disulfide core domain protein 2,Inverse variance weighted,4,0.5 [0.24-1.02],0.0577223011959819,trans
Chapter IX Diseases of the circulatory system,I9_VASCINT,ANGPT2,Angiopoietin-2,Inverse variance weighted,7,0.66 [0.33-1.34],0.253578766093165,trans
Chapter IX Diseases of the circulatory system,I9_VASCINT,GDF15,Growth/differentiation factor 15,Wald ratio,1,3.89 [0.27-56.1],0.318719672169241,trans
Chapter IX Diseases of the circulatory system,I9_VASCINT,TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,Inverse variance weighted,3,0.8 [0.27-2.38],0.68833246149936,trans
